Invention Grant
- Patent Title: Immunoadsorbent compositions comprising hyaluronic acid oligosaccharides
-
Application No.: US14421555Application Date: 2013-08-12
-
Publication No.: US09719987B2Publication Date: 2017-08-01
- Inventor: Rafael Mañez Mendiluce
- Applicant: FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)
- Applicant Address: ES L'Hospitalet de Llobregat
- Assignee: FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)
- Current Assignee: FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)
- Current Assignee Address: ES L'Hospitalet de Llobregat
- Agency: KramerAmado, P.C.
- Priority: EP12382325 20120813
- International Application: PCT/EP2013/066825 WO 20130812
- International Announcement: WO2014/026950 WO 20140220
- Main IPC: A61K31/702
- IPC: A61K31/702 ; G01N33/53 ; G01N33/548 ; G01N33/564 ; A61K35/16 ; A61K35/18
Abstract:
The present invention relates to methods for determining the probability of transplant rejection based on the determination in the subject recipient of the transplant of the levels of antibodies specific for hyaluronic acid. The invention relates as well to methods for attenuating transplant rejection and compositions to prevent transplant rejection based on the depletion of anti-hyaluronic acid antibodies from the subject.
Public/Granted literature
- US20150192576A1 METHODS AND REAGENTS FOR PREVENTION AND/OR TREATMENT OF TRANSPLANT REJECTION Public/Granted day:2015-07-09
Information query
